Document:

EX-10.37

Exhibit 10.37

AMENDMENT TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT

     THIS AMENDMENT TO THE DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT (the “Amendment”) is entered
into as of the 23rd day of December 2008, by and between Banner Pharmacaps Inc., a
Delaware corporation (“Banner”), and Noven Therapeutics, LLC, (f/k/a JDS Pharmaceuticals, LLC,
(“Noven”), a Delaware limited liability corporation.

RECITALS

A.     Banner and Noven entered into a Development, License and Supply Agreement dated April 26, 2007
(the “Supply Agreement”) relating to the development, registration, sale and marketing of certain
valproic acid products, including the Valproic Acid VersatrolTM Product (as defined in the Supply
Agreement).

B.     The parties have agreed to amend the Supply Agreement to remove all reference to the Valproic
Acid VersatrolTM Product.

AGREEMENT

     Therefore, in consideration of the foregoing recitals, which expressly are incorporated by
reference herein and in consideration of the covenants, representations and agreements contained
below, the sufficiency of which is acknowledged, the parties, intending to be legally bound, hereby
agree as follows:

1.     The Supply Agreement is hereby amended to remove all references to the Valproic Acid VersatrolTM
Product, with the effect that all rights and obligations of Noven and Banner related to the
Valproic Acid VersatrolTM Product under the Supply Agreement are terminated, including, but not
limited to, any obligation of Noven to make milestone payments not yet due under Section 2.2(c),
(d) or (e) of the Supply Agreement. Further, Banner is relieved from all obligations to Noven with
respect to the Valproic Acid VersatrolTM Product.

2.     To avoid doubt, this Amendment does not in any manner affect the parties’ continuing rights and
obligations under the Supply Agreement with respect to the Valproic Acid EnteriCareTM Product.
Further, following execution and delivery of this Amendment by both parties, Banner shall have
unrestricted rights to commercialize the Valproic Acid VersatrolTM Product, including, but not
limited to, the right to offer to any third party exclusive rights to the Valproic Acid VersatrolTM
Product in any dosage forms, in any dosage strengths and for any indications, notwithstanding any
provision of the Supply Agreement to the contrary.

3.     Except as expressly revised by this Amendment, the Supply Agreement shall remain in full force
and effect in accordance with its terms and conditions. Banner and Noven agree that to the extent
any of the terms of the Supply Agreement (as previously amended) are inconsistent or conflict with
the terms of this Amendment, such terms of
the Supply Agreement are hereby amended to be consistent with the intent and terms of this
Amendment.

1

 

     IN WITNESS HEREOF, the parties hereto have duly executed and delivered, or caused to be duly
executed and delivered, this Amendment as of the day and year first above written.

	 	 	 	 	 
	BANNER PHARMACAPS INC. 

 	 
	By:  	/s/ Charles L. Cain
 	 
	 	Name:  	Charles L. Cain                       	 
	 	Title:  	Global VP — Legal & HR 	 
	 

	 	 	 	 	 
	NOVEN THERAPEUTICS, LLC

 	 
	By:  	/s/ Jeff Mihm
 	 
	 	Name:  	Jeff Mihm 	 
	 	Title:  	Authorized Representative 	 
	 

2EX-10.6

Exhibit 10.6

AMENDED AND RESTATED SEPARATION PAY AGREEMENT

     This Amended and Restated Separation Pay Agreement (the “Agreement”) by and between Lodgian,
Inc. (“Company”), and James McGrath (“You” or “Your”) (collectively, the “Parties”), is entered
into and effective as of the 29th of March, 2007 (the “Effective Date”).1

     WHEREAS, You will continue to be employed by the Company;

     WHEREAS, the Company and You agreed to certain post-termination payment obligations following
a Change In Control pursuant to the Separation Pay Agreement between You and the Company dated
September 9, 2006 (the “Prior Agreement”); and

     WHEREAS, the Company and You have agreed to modify the terms and conditions of such payment
obligations as set forth below.

     NOW, THEREFORE, in consideration of Company’s agreement to continue to employ You and in
further consideration of the mutual agreements set forth herein, it is agreed:

1. Termination of Prior Agreement. The Parties hereby terminate the Prior Agreement effective on the Effective Date. The Parties
acknowledge and agree that the termination of the Prior Agreement does not and shall not result in
the vesting, acceleration, or triggering of any employment benefit in Your favor, including, but
not limited to, any post-termination payment obligation or any separation payment or benefit, or
any other right which You may have as a shareholder, officer, or employee, or under any agreement
or understanding between You and the Company, including, but not limited to, the Prior Agreement.

2. At-will Employment. This Agreement does not create a contract of employment. Your employment with the Company is
and remains at all times an at-will relationship. This means that at either Your option or the
Company’s option, Your employment may be terminated at any time, with or without Cause or with or
without notice. This Agreement does not alter the at-will employment relationship.

3. Post-Termination Payment Obligations.

	 	(a)	 	If Your employment terminates for any of the reasons set forth in sub-section 6(c)
below, then the Company shall pay You all accrued but unpaid wages, based on Your then
current Base Salary, through the termination date. The Company shall have no other
obligations to You, including under any provision of this Agreement, Company policy, or
otherwise; provided, however, You shall continue to be bound by (a) the restrictive
covenants set forth in Section 7 below, and (b) all other post-termination obligations to
which You are subject.
	 
	 	(b)	 	If Your employment terminates for any of the reasons set forth in sub-sections 6(a),
6(b), 6(d) or 6(e) below, and Section 4 below does not apply, then the Company will pay You
all accrued but unpaid Base Salary through the termination date. In addition, upon Your
“separation from service” (within the meaning of Internal Revenue Code (“Code”) §
409A(a)(2)(A)(i)), the

 

			
	1	 	Unless otherwise indicated, all capitalized terms used in
this Agreement are defined in the “Definitions” section of Exhibit A. Exhibit
A is incorporated by reference and is included in the definition of
“Agreement.”

- 1 -

 

	 	 	 	Company shall: (i) pay You (or Your estate if applicable), within
thirty (30) days of Your termination date, a lump sum payment equal to fifty percent (50%) of Your then current
annual Base Salary; (ii) reimburse Your and Your eligible dependents’ COBRA premiums under
the Company’s major medical group health plan on a monthly basis for a period of six (6)
months; (iii) pay You (or Your estate if applicable), within thirty (30) days of Your
termination date, a lump sum payment of Thirty Seven Thousand Five Hundred One Dollars and
Fifty Cents ($37,501.50); and (iv) notwithstanding anything to the contrary in any
applicable documents evidencing a grant of an award under the Lodgian, Inc. 2002 Stock
Incentive Plan or any similar plan, accelerate the vesting of any such awards granted to You
by the Company (the “Award(s)”) so that any such Award(s) comprised of options to purchase
Company stock shall be immediately exercisable in full, or so that all vesting restrictions
upon any such Award(s) comprised of restricted stock shall lapse (collectively, the payments
and benefits set forth in the preceding sub-clauses (i) – (iv) to be referred to as the
“Separation Benefits”). The Company shall have no other obligations to You, including under
this Agreement, any Company policy, or otherwise. The Separation Benefits shall constitute
full satisfaction of the Company’s obligations under this Agreement, the Lodgian, Inc.
Executive Incentive Plan (the “Incentive Plan”), any Company policy, or otherwise. The
Company’s obligation to provide the Separation Benefits shall be subject to Section 5 below
and conditioned upon Your satisfaction of the following conditions (the “Separation Benefits
Conditions”):

	 	(i)	 	Execution and non-revocation of a Separation & Release Agreement in a form prepared
by the Company, which includes, but is not limited to, Your releasing the Company from any
and all liability and claims of any kind; and
	 
	 	(ii)	 	Your compliance with (a) the restrictive covenants set forth in Section 7 below,
and (b) all other post-termination obligations to which You are subject.

	 	 	 	If You do not execute an effective Separation & Release Agreement as set forth above,
the Company shall have no obligation to provide the Separation Benefits to You under this
sub-section. The Company’s obligation to provide the Separation Benefits set forth above
shall terminate immediately upon any breach by You of any post-termination obligations to
which You are subject.

4. Post Change In Control Payment Obligations.

	 	(a)	 	Change In Control Separation Benefits. If, within
sixty (60) days before or three hundred sixty five (365) days after a Change
in Control, this Agreement terminates for the reasons set forth in Sections 6(d) or 6(e)
below, then the Company will pay You all accrued but unpaid Base Salary through the
termination date. In addition, upon Your “separation from service” (within the meaning of
Code § 409A(a)(2)(A)(i)), the Company shall: (i) pay You a lump sum payment equal to Your
then current annual Base Salary, to be paid within thirty (30) days after the date of
termination; (ii) pay You a lump sum payment of Seventy Five Thousand Three Dollars
($75,003.00) to be paid within thirty (30) days after the date of termination; (iii)
reimburse Your and Your eligible dependents’ COBRA premiums under the Company’s major
medical group health plan on a monthly basis for a period of twelve (12) months; and (iv)
notwithstanding anything to the contrary in any applicable documents evidencing a grant of
an award under the Lodgian, Inc. 2002 Stock Incentive Plan or any similar plan, accelerate
the vesting of any such awards granted to You by the Company (the “Award(s)”) so that any
such Award(s) comprised of options to purchase Company stock shall be immediately
exercisable in full, or so that all vesting

- 2 -

 

	 	 	 	restrictions upon any such Award(s) comprised of
restricted stock shall lapse (collectively, the payments and benefits set forth in the
preceding sub-clauses (i) — (iv) to be referred to as the
“Change In Control Separation Benefits”). Your right to receive the Change In Control
Separation Benefits shall be subject to Section 5 below and the Separation Benefits
Conditions set forth in Section 3(b) above. The Change In Control Separation Benefits to be
provided under this Section 4 shall constitute full satisfaction of the Company’s
obligations under this Agreement, the Incentive Plan, any Company policy, or otherwise.

	 	(b)	 	Change In Control Completion Bonus. In the event of the closing of any
transaction constituting a Change In Control, provided (1) such closing occurs on or before
December 31, 2008, and (2) You are employed within sixty (60) days before or on the date of
such closing, then the Company shall (i) pay You a lump sum payment equal to twenty-five
percent (25%) of Your then current annual Base Salary; (ii) pay You a lump sum payment
Eighteen Thousand Seven Hundred Fifty Dollars and Seventy Five Cents ($18,750.75), and (ii)
grant You Twenty Seven Thousand Two Hundred (27,200) restricted shares of Common Stock
subject to the terms and conditions of the Employee Restricted Stock Agreement attached as
Exhibit B (sub-sections (i) through (iii) collectively, the “Completion Bonus”).
Notwithstanding anything to the contrary set forth in the Incentive Plan or this Agreement,
the Completion Bonus, if any, shall fully satisfy the Company’s payment obligations under
the Incentive Plan for the calendar year in which the closing occurs. The Company shall pay
You the Completion Bonus within thirty (30) days following the closing of the Change In
Control; provided, however, the Company’s obligation to provide the Completion Bonus shall
be subject to Section 5 below and conditioned upon Your execution and non-revocation of a
Release Agreement in a form prepared by the Company, which includes, but is not limited to,
Your releasing the Company from any and all liability and claims of any kind.

5. Delay In Payments To Comply With Code § 409A. Notwithstanding any provision of this Agreement to the contrary, if You are a “specified
employee” within the meaning of Code §409A(a)(2)(B)(i), then any payment that is required to be
made under Section 3 or Section 4 above within the first six (6) months following Your “separation
from service” (within the meaning of Code § 409A(a)(2)(A)(i)) shall be paid on the date that is the
first business day of the seventh (7th) month after the date of Your “separation from service” and
shall be paid in a single lump sum payment, provided that You satisfy the Separation Benefits
Conditions. The provisions of this Section are intended to require a delay in a payment under
Section 3 or Section 4 above only to the extent that such a delay is required in order for such
payment to comply with Code § 409A(a)(2)(B)(i), and shall not otherwise apply. In addition,
immediately prior to Your “separation from service” (within the meaning of Code §409A(a)(2)(A)(i),
the Company shall (i) establish an irrevocable grantor trust (the “Trust”) that shall have terms
designed to be consistent with those allowed under the model trust set forth in IRS Revenue
Procedure 92-64 and that shall have an independent financial institution as trustee, (ii)
contribute to the Trust the amount of each payment delayed for six (6) months under this Section as
of the date such payment would otherwise be required to be paid absent the provisions of this
Section applying to delay such payment, and (iii) provide the trustee of the Trust with a written
direction to (A) hold said amount in a segregated account for Your benefit and (B) pay from such
segregated account all payments delayed under this Section (with earnings thereon) to You on the
first business day of the seventh (7th) month after the date of Your “separation from service.”
Trust assets shall be invested in the highest-yielding available money market account of the
trustee (or, if the trustee does not have such an account, then the highest-yielding available
money market account of Bank of America), and earnings on amounts contributed to the Trust for
purposes of the preceding sentence shall be determined based on such chosen investment. All
expenses of the trustee shall be paid by the Company and not from the Trust’s assets. The
provisions of this Section shall not be required if You so agree in writing. Upon the trustee’s
final payment of the entire corpus of the Trust in a single lump sum, the Trust shall terminate.

- 3 -

 

6. Termination of Employment. As an at-will employee, Your employment may be terminated at any time for any or no reason,
including, but not limited to:

	 	(a)	 	Your death;
	 
	 	(b)	 	Your disability which renders You unable to perform the essential functions of Your job
with or without reasonable accommodation;
	 
	 	(c)	 	For Cause. For Cause shall mean a termination by the Company because of any one
of the following events:

	 	(i)	 	Your willful refusal to follow the lawful direction of the CEO and/or the person to
whom You report or Your material failure to perform Your duties (other than by reason of
Disability, as defined in sub-paragraph 6(b) above), in either case, only after You have
been given written notice by the CEO and/or the person to whom You report detailing the
directives You have refused to follow or the duties You have failed to perform and at least
30 days to cure;
	 
	 	(ii)	 	Your material and willful failure to comply with Company policies, only after You
have been given written notice by the CEO and/or the person to whom You report detailing the
policies with which You have failed to comply and at least 30 days to cure;
	 
	 	(iii)	 	Your actively seeking a position with another business, applying for such
position, and being likely to accept such a position without the Company’s written consent;
	 
	 	(iv)	 	Your engaging in any of the following conduct:

	 	(1)	 	an act of fraud or dishonesty that materially harms the Company or its
affiliates,
	 
	 	(2)	 	a felony or any violation of any federal or state securities law or Your
being enjoined from violating any federal or state securities law or being
determined to have violated any such law;
	 
	 	(3)	 	gross negligence in connection with any property or activity of the
Company and/or its subsidiaries, affiliates or successors;
	 
	 	(4)	 	repeated and intemperate use of alcohol or illegal drugs after written
notice from the CEO and/or the person to whom You report;
	 
	 	(5)	 	material breach of any of Your obligations under any agreement between You
and the Company (other than by reason of physical or mental illness or
injury), but only after You have been given written notice of the breach by
the CEO and/or the person to whom You report and at least thirty (30) days to
cure;
	 
	 	(6)	 	becoming barred or prohibited by the SEC from holding Your position with
the Company.

- 4 -

 

	 	(v)	 	Your resignation from the Company without Good Reason;

	 	(d)	 	Your resignation from the Company for Good Reason.

	 	(e)	 	Without Cause. Without Cause means any termination of employment by Company
which is not defined in sub-paragraphs 6(a) – 6(d) above.

7. Restrictive Covenants. You acknowledge and agree that: (a) Your position is a position of trust and responsibility with
access to Confidential Information, Trade Secrets, and information concerning employees, customers,
and prospective customers of the Company; (b) the Trade Secrets and Confidential Information, and
the relationship between the Company and each of its Employees, Customers, and Prospective
Customers, are valuable assets of the Company and may not be used for any purpose other than the
Company’s business; and (c) the restrictions contained in this Section 7 are reasonable and
necessary to protect the legitimate business interests of the Company, and will not impair or
infringe upon Your right to work or earn a living after Your employment with the Company ends.

	 	(a)	 	Trade Secrets and Confidential Information. You represent and warrant that: (i) You are not subject to any legal or contractual
duty or agreement that would prevent or prohibit You from performing the duties contemplated
by this Agreement or otherwise complying with this Agreement, and (ii) You are not in breach
of any legal or contractual duty or agreement, including any agreement concerning trade
secrets or confidential information owned by any other party.

	 	 	 	     You agree that You will not: (i) use, disclose, or reverse engineer the Trade Secrets
or the Confidential Information for any purpose other than the Company’s Business, except as
authorized in writing by the Company; (ii) during Your employment with the Company, use,
disclose, or reverse engineer (a) any confidential information or trade secrets of any
former employer or third party, or (b) any works of authorship developed in whole or in part
by You during any former employment or for any other party, unless authorized in writing by
the former employer or third party; or (iii) upon Your resignation or termination (a) retain
Trade Secrets or Confidential Information, including any copies existing in any form
(including electronic form), which are in Your possession or control, or (b) destroy,
delete, or alter the Trade Secrets or Confidential Information without the Company’s written
consent.

	 	 	 	     The obligations under this sub-section shall: (i) with regard to the Trade Secrets,
remain in effect as long as the information constitutes a trade secret under applicable law,
and (ii) with regard to the Confidential Information, remain in effect during the Restricted
Period. The confidentiality, property, and proprietary rights protections available in this
Agreement are in addition to, and not exclusive of, any and all other rights to which the
Company is entitled under federal and state law, including, but not limited to, rights
provided under copyright laws, trade secret and confidential information laws, and laws
concerning fiduciary duties.

	 	(b)	 	Non-Disclosure of Customer or Prospective Customer Information. During the Restricted Period, You shall not, except as authorized by the Company, divulge
or make accessible to any person or entity (i) the names of Customers or Prospective
Customers, or (ii) any information contained in a Customer’s or Prospective Customer’s
account.

	 	(c)	 	Non-Solicitation of Customers. During the Restricted Period, You shall not, directly or indirectly, solicit any Customer
of the Company for the purpose of selling or providing any products or services competitive
with the Business. The restrictions set forth in this sub-section

- 5 -

 

	 	 	 	apply only to Customers
with whom You had Contact during the term of Your employment. Nothing in this sub-section
shall be construed to prohibit You from soliciting any Customer of the Company for the
purpose of selling or providing any products or services competitive with the Business: (i)
which You never sold or provided while employed by the Company; (ii) to a Customer that
explicitly severed its business relationship with the Company unless You, directly
or indirectly, caused or encouraged the Customer to sever the relationship; or (iii) which
products or services the Company no longer offers.

	 	(d)	 	Non-Solicitation of Prospective Customers. During the Restricted Period, You
shall not, directly or indirectly, solicit any Prospective Customer of the Company for the
purpose of selling or providing any products or services competitive with the Business. The
restrictions set forth in this sub-section apply only to Prospective Customers with whom You
had Contact during the last year of Your employment with the Company (or during Your
employment if employed less than a year). Nothing in this sub-section shall be construed to
prohibit You from soliciting any Prospective Customer of the Company for the purpose of
selling or providing any products or services competitive with the Business which the
Company no longer offers.

	 	(e)	 	Non-Recruit of Employees. During the Restricted Period, You shall not, directly or indirectly, solicit, recruit, or
induce any Employee to (i) terminate his or her employment relationship with the Company, or
(ii) work for any other person or entity engaged in the Business. The restrictions set
forth in this sub-section shall apply only to Employees (a) with whom You had Material
Interaction, or (b) You, directly or indirectly, supervised.

	 	(f)	 	Post-Employment Disclosure. During the Restricted Period, You shall provide a copy of this Agreement to persons and/or
entities for whom You work or consult as an owner, partner, joint venturer, employee or
independent contractor.

	 	(g)	 	Injunctive Relief. You agree that if You breach any portion of this Section 7: (i) the Company would suffer
irreparable harm; (ii) it would be difficult to determine damages, and money damages alone
would be an inadequate remedy for the injuries suffered by the Company, and (iii) if the
Company seeks injunctive relief to enforce this Agreement, You shall waive and shall not (a)
assert any defense that the Company has an adequate remedy at law with respect to the
breach, (b) require that the Company submit proof of the economic value of any Trade Secret
or Confidential Information, or (c) require the Company to post a bond or any other
security. Nothing contained in this Agreement shall limit the Company’s right to any other
remedies at law or in equity.

	 	(h)	 	Independent Enforcement. The covenants set forth in this Section 7 shall be construed as agreements independent of
(i) any other agreements, or (ii) any other provision in this Agreement, and the existence
of any claim or cause of action by You against the Company, whether predicated on this
Agreement or otherwise, regardless of who was at fault and regardless of any claims that
either You or the Company may have against the other, shall not constitute a defense to the
enforcement by the Company of the covenants set forth in this Section 7. The Company shall
not be barred from enforcing the restrictive covenants set forth in this Section 7 by reason
of any breach of (i) any other part of this Agreement, or (ii) any other agreement with You.

8. Release. You release and discharge the Company from any claim or liability, whether known or unknown,
arising out of any event, act or omission occurring on or before the day You sign this Agreement,
including, but not limited to, claims arising out of Your employment, claims arising out of or

- 6 -

 

relating to the Prior Agreement or the termination of the Prior Agreement, claims arising by virtue
of Your status as a shareholder of Company, claims for breach of contract, tort, negligent hiring,
negligent training, negligent supervision, negligent retention, employment discrimination,
retaliation, or harassment, claims arising out of or relating to equity or other ownership interest
in Company, as well as any other statutory or common law claims, at law or in equity, recognized
under any federal, state, or local law. You also release any claims for unpaid back pay, sick pay, vacation pay, expenses,
bonuses, commissions, attorneys’ fees, or any other compensation.

9. Entire Agreement. This Agreement, including Exhibit A and Exhibit B which are incorporated by reference,
constitutes the entire agreement between the Parties concerning the subject matter of this
Agreement. This Agreement supersedes any prior communications, agreements, or understandings,
whether oral or written, between the Parties relating to the subject matter of this Agreement.
Other than the terms of this Agreement, no other representation, promise or agreement has been made
with You to cause You to sign this Agreement.

10. Governing Law. The laws of the State of Georgia shall govern this Agreement. If Georgia’s conflict of law
rules would apply another state’s laws, the Parties agree that Georgia law shall still govern.

11. Waiver. The Company’s failure to enforce any provision of this Agreement shall not act as a waiver of
that or any other provision. The Company’s waiver of any breach of this Agreement shall not act as
a waiver of any other breach.

12. Severability. The provisions of this Agreement are severable. If any provision is determined to be invalid,
illegal, or unenforceable, in whole or in part, the remaining provisions and any partially
enforceable provisions shall remain in full force and effect.

13. Amendments. As a condition of employment and a material term under this Agreement, You agree that, at any
time during Your employment, You shall sign an amendment to this Agreement which would modify the
Restrictive Covenants in Section 7 of this Agreement (the “Amendment”) based on changes to Your
duties or changes in the law regarding restrictive covenants. You agree that You shall not be
entitled to any additional consideration to execute the Amendment. You agree that Your refusal to
sign any such Amendment shall constitute a material breach of this Agreement. This Agreement may
not otherwise be amended or modified except in writing signed by both Parties.

     The Parties further understand and acknowledge that modifications to this Agreement may be
appropriate after final regulations are issued under Code § 409A. The Parties agree to negotiate
in good faith regarding any such modifications that may be required in order to comply with Code §
409A and avoid additional and accelerated taxation to You pursuant to Code § 409A.

14. Successors and Assigns. This Agreement shall be assignable to, and shall inure to the benefit of, the Company’s
successors and assigns, including, without limitation, successors through merger, name change,
consolidation, or sale of a majority of the Company’s stock or assets, and shall be binding upon
You and Your heirs and assigns.

15. Consent to Jurisdiction and Venue. You agree that any claim arising out of or relating to this Agreement shall be brought in a
state or federal court of competent jurisdiction in Georgia. You consent to the personal
jurisdiction of the state and/or federal courts located in Georgia. You waive (i) any objection to
jurisdiction or venue, or (ii) any defense claiming lack of jurisdiction or improper venue, in any
action brought in such courts.

- 7 -

 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the Effective Date.

	 	 	 	 	 	 	 
	Lodgian, Inc.

	 	James McGrath
	 
	 	 
	By:	 	/s/ Edward J. Rohling

	 	/s/ James McGrath
	 	 	 

	 	 	 
	 
	 	 	 
	Name:
	 	Edward J. Rohling
	 	 
	 	 	 
	 	 	 
	 
	 	 
	Title:
	 	President & CEO
	 	 
	 	 	 
	 	 

- 8 -

 

EXHIBIT A

DEFINITIONS

	A.	 	“Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule
12b -2 promulgated under the Securities Exchange Act of 1934, as amended.
	 
	B.	 	“Base Salary” means the wages the Company pays You on an annual basis, exclusive of all
benefits, bonuses, equity, commissions, or any other incentive-based compensation.
	 
	C.	 	“Beneficial Owner” shall have the meaning ascribed to that term in Rule 13d-3 promulgated
under the Securities Exchange Act of 1934, as amended.
	 
	D.	 	“Business” means the business of owning and operating hotels including, but not limited to,
full-service hotels which have food and beverage operations and meeting spaces.
	 
	E.	 	“Change in Control” means:

	 	(i)	 	when any Person (other than the Company, any Subsidiary of the Company, any
employee benefit plan of the Company or of any Subsidiary of the Company, or any person
or entity organized, appointed or established by the Company or any Subsidiary of the
Company for or pursuant to the terms of any such plan), alone or together with its
Affiliates and Associates (collectively, an “Acquiring Person”), shall become the
Beneficial Owner of 40 percent or more of the then outstanding shares of Common Stock
or the Combined Voting Power of the Company,
	 
	 	(ii)	 	when, during any period of two consecutive years, individuals who at the
beginning of such period constitute the Board of Directors of the Company (the
“Board”), and any new director (other than a director who is a representative or
nominee of an Acquiring Person) whose election by the Board or nomination for election
by the Company’s shareholders was approved by a vote of at least a majority of the
directors then still in office who either were directors at the beginning of the period
or whose election or nomination for election was previously so approved (collectively,
the “Continuing Directors”), cease for any reason to constitute a majority of the
Board,
	 
	 	(iii)	 	the consummation of a merger or consolidation of the Company with any other
corporation, other than a merger or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing to represent
(either by remaining outstanding or by being converted into voting securities of the
surviving entity or any Parent of such surviving entity) at least a majority of the
Combined Voting Power of the Company, such surviving entity, or the Parent of such
surviving entity outstanding immediately after such merger or consolidation;
	 
	 	(iv)	 	the consummation of a plan of reorganization (other than a reorganization under
the United States Bankruptcy Code) or complete liquidation of the Company or an
agreement for the sale or disposition by the Company of all or substantially all of the
Company’s assets, other than a sale of all or substantially all of the Company’s assets
to a transferee, the majority of whose voting securities are held by the Company; or

- 9 -

 

	 	(v)	 	when the shareholders of the Company approve an agreement for the sale or
disposition by the Company of all or substantially all of the Company’s assets in a
transaction or series of transactions to an entity that is not owned, directly or
indirectly, by the Company’s common stock shareholders in substantially the same
proportions as the owners of the Company’s common stock before such transaction or
series of transactions.

	F.	 	“Combined Voting Power” means the combined voting power of the Company’s or other relevant
entity’s then outstanding voting securities.

	G.	 	“Common Stock “ means the Common Stock, par value $.01 per share, of the Company.

	H.	 	“Confidential Information” means (a) information of the Company, to the extent not considered
a Trade Secret under applicable law, that (i) relates to the business of the Company, (ii)
possesses an element of value to the Company, (iii) is not generally known to the Company’s
competitors, and (iv) would damage the Company if disclosed, and (b) information of any third
party provided to the Company which the Company is obligated to treat as confidential,
including, but not limited to, information provided to the Company by its licensors,
suppliers, or customers. Confidential Information includes, but is not limited to, (i) future
business plans, (ii) the composition, description, schematic or design of products, future
products or equipment of the Company or any third party, (iii) communication systems, audio
systems, system designs and related documentation, (iv) advertising or marketing plans, (v)
information regarding independent contractors, employees, clients, licensors, suppliers,
customers, or any third party, including, but not limited to, customer lists compiled by the
Company, and customer information compiled by the Company, and (vi) information concerning the
Company’s or a third party’s financial structure and methods and procedures of operation.
Confidential Information shall not include any information that (i) is or becomes generally
available to the public other than as a result of an unauthorized disclosure, (ii) has been
independently developed and disclosed by others without violating this Agreement or the legal
rights of any party, or (iii) otherwise enters the public domain through lawful means.

	I.	 	“Contact” means any interaction between You and a Customer or Prospective Customer which
takes place in an effort to perform services on behalf of the Company or to establish,
maintain, and/or further a business relationship on behalf of the Company.

	J.	 	“Customer” means any person or entity to whom the Company has sold its products or services..

	K.	 	“Employee” means any person who (i) is employed by the Company at the time Your employment
with the Company ends, or (ii) was employed by the Company during the last year of Your
employment with the Company (or during Your employment if employed less than a year).

	L.	 	“Good Reason” shall exist if (i) the Company, without Your written consent, (A) takes any
action which results in the material reduction of Your then current duties or
responsibilities, (B) reduces Your then-current Base Salary, (C) reduces the benefits to which
You are entitled on the Effective Date, unless a similar reduction is made for other executive
employees, (D) commits a material breach of this Agreement, or (E) requires You to relocate
more than fifty (50) miles from the location where you provide services to the Company as of
the Effective Date; (ii) You provide written notice to the Company of such action and provide
the Company with thirty (30) days to remedy such action (the “Cure Period”), (iii) the Company
fails to remedy such action within the Cure Period, and (iv) You resign within ten (10) days
of the expiration of the Cure Period. Good Reason shall not include any isolated,
insubstantial or inadvertent action that (i) is not taken in bad faith, and (ii) is remedied
by the Company within the Cure Period.

- 10 -

 

	M.	 	“Material Interaction” means any interaction between You and an Employee which relates or
related, directly or indirectly, to the performance of Your duties for the Company.

	N.	 	“Parent” means any corporation which is a “parent corporation” within the meaning of Section
424(e) of the Internal Revenue Code of 1986, as amended, with respect to the relevant entity.

	O.	 	“Person” means any person, entity or “group” within the meaning of Section 13(d)(3) or
Section 14(d)(2) of the Exchange Act.

	P.	 	“Prospective Customer” means any person or entity to whom the Company has solicited to sell
its products or services.

	Q.	 	“Restricted Period” means the time period during Your employment with the Company, and for
one (1) year after Your employment with the Company ends.

	R.	 	“Subsidiary” means any corporation which is a “subsidiary corporation” within the meaning of
Section 424(f) of the Internal Revenue Code of 1986, as amended, with respect to the Company.

	S.	 	“Trade Secrets” means information of the Company, and its licensors, suppliers, clients, and
customers, without regard to form, including, but not limited to, technical or nontechnical
data, a formula, a pattern, a compilation, a program, a device, a method, a technique, a
drawing, a process, financial data, financial plans, product plans, a list of actual
customers, clients, licensors, or suppliers, or a list of potential customers, clients,
licensors, or suppliers which is not commonly known by or available to the public and which
information (i) derives economic value, actual or potential, from not being generally known
to, and not being readily ascertainable by proper means by, other persons who can obtain
economic value from its disclosure or use, and (ii) is the subject of efforts that are
reasonable under the circumstances to maintain its secrecy.

- 11 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]